vs

Side-by-side financial comparison of Foghorn Therapeutics Inc. (FHTX) and INTERGROUP CORP (INTG). Click either name above to swap in a different company.

INTERGROUP CORP is the larger business by last-quarter revenue ($17.3M vs $9.2M, roughly 1.9× Foghorn Therapeutics Inc.). INTERGROUP CORP runs the higher net margin — 8.8% vs -234.3%, a 243.0% gap on every dollar of revenue. On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs 19.8%). Over the past eight quarters, Foghorn Therapeutics Inc.'s revenue compounded faster (35.3% CAGR vs 7.8%).

Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.

Intergroup Corp is a diversified holding firm operating two core segments: real estate and hotel operations. It owns, manages and leases commercial and residential properties across the U.S., and runs limited-service hotels for leisure and business travelers.

FHTX vs INTG — Head-to-Head

Bigger by revenue
INTG
INTG
1.9× larger
INTG
$17.3M
$9.2M
FHTX
Growing faster (revenue YoY)
FHTX
FHTX
+204.0% gap
FHTX
223.8%
19.8%
INTG
Higher net margin
INTG
INTG
243.0% more per $
INTG
8.8%
-234.3%
FHTX
Faster 2-yr revenue CAGR
FHTX
FHTX
Annualised
FHTX
35.3%
7.8%
INTG

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
FHTX
FHTX
INTG
INTG
Revenue
$9.2M
$17.3M
Net Profit
$-21.7M
$1.5M
Gross Margin
Operating Margin
-258.2%
11.6%
Net Margin
-234.3%
8.8%
Revenue YoY
223.8%
19.8%
Net Profit YoY
-11.1%
155.6%
EPS (diluted)
$-0.35
$0.71

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FHTX
FHTX
INTG
INTG
Q4 25
$9.2M
$17.3M
Q3 25
$8.2M
$17.9M
Q2 25
$7.6M
$16.2M
Q1 25
$6.0M
$16.8M
Q4 24
$2.9M
$14.4M
Q3 24
$7.8M
$16.9M
Q2 24
$6.9M
$13.4M
Q1 24
$5.0M
$14.9M
Net Profit
FHTX
FHTX
INTG
INTG
Q4 25
$-21.7M
$1.5M
Q3 25
$-15.8M
$-535.0K
Q2 25
$-17.9M
$-2.2M
Q1 25
$-18.8M
$-578.0K
Q4 24
$-19.5M
$-2.7M
Q3 24
$-19.1M
$-398.0K
Q2 24
$-23.0M
$-4.9M
Q1 24
$-25.0M
$-3.2M
Operating Margin
FHTX
FHTX
INTG
INTG
Q4 25
-258.2%
11.6%
Q3 25
-226.9%
15.3%
Q2 25
-279.2%
8.1%
Q1 25
-385.0%
14.0%
Q4 24
-840.5%
5.9%
Q3 24
-305.5%
18.5%
Q2 24
-386.6%
3.7%
Q1 24
-558.3%
4.8%
Net Margin
FHTX
FHTX
INTG
INTG
Q4 25
-234.3%
8.8%
Q3 25
-194.4%
-3.0%
Q2 25
-237.3%
-13.9%
Q1 25
-316.4%
-3.4%
Q4 24
-682.9%
-18.9%
Q3 24
-244.9%
-2.4%
Q2 24
-333.6%
-36.7%
Q1 24
-495.4%
-21.3%
EPS (diluted)
FHTX
FHTX
INTG
INTG
Q4 25
$-0.35
$0.71
Q3 25
$-0.25
$-0.25
Q2 25
$-0.28
Q1 25
$-0.30
$-0.27
Q4 24
$-0.23
$-1.26
Q3 24
$-0.31
$-0.18
Q2 24
$-0.45
Q1 24
$-0.59
$-1.44

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FHTX
FHTX
INTG
INTG
Cash + ST InvestmentsLiquidity on hand
$80.9M
$7.5M
Total DebtLower is stronger
$233.2M
Stockholders' EquityBook value
$-108.5M
$-85.2M
Total Assets
$198.1M
$101.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FHTX
FHTX
INTG
INTG
Q4 25
$80.9M
$7.5M
Q3 25
$89.3M
$6.0M
Q2 25
$72.6M
$6.1M
Q1 25
$61.0M
$4.8M
Q4 24
$55.5M
$15.4M
Q3 24
$57.7M
$12.2M
Q2 24
$138.9M
$11.6M
Q1 24
$79.3M
$19.5M
Total Debt
FHTX
FHTX
INTG
INTG
Q4 25
$233.2M
Q3 25
$237.8M
Q2 25
$240.5M
Q1 25
$241.5M
Q4 24
$227.2M
Q3 24
$218.1M
Q2 24
$225.7M
Q1 24
$225.0M
Stockholders' Equity
FHTX
FHTX
INTG
INTG
Q4 25
$-108.5M
$-85.2M
Q3 25
$-89.7M
$-86.7M
Q2 25
$-76.7M
$-86.1M
Q1 25
$-61.7M
$-84.5M
Q4 24
$-45.5M
$-83.9M
Q3 24
$-28.3M
$-80.9M
Q2 24
$-14.3M
$-80.3M
Q1 24
$-97.5M
$-76.4M
Total Assets
FHTX
FHTX
INTG
INTG
Q4 25
$198.1M
$101.1M
Q3 25
$205.0M
$102.5M
Q2 25
$226.2M
$104.1M
Q1 25
$258.7M
$103.2M
Q4 24
$284.0M
$110.6M
Q3 24
$308.4M
$109.3M
Q2 24
$328.6M
$107.8M
Q1 24
$255.0M
$119.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FHTX
FHTX
INTG
INTG
Operating Cash FlowLast quarter
$-22.3M
$-23.0K
Free Cash FlowOCF − Capex
$-481.0K
FCF MarginFCF / Revenue
-2.8%
Capex IntensityCapex / Revenue
0.0%
2.6%
Cash ConversionOCF / Net Profit
-0.02×
TTM Free Cash FlowTrailing 4 quarters
$739.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FHTX
FHTX
INTG
INTG
Q4 25
$-22.3M
$-23.0K
Q3 25
$-18.9M
$-296.0K
Q2 25
$-21.0M
$5.9M
Q1 25
$-24.0M
$-854.0K
Q4 24
$-24.5M
$-781.0K
Q3 24
$-21.0M
$3.4M
Q2 24
$-25.5M
$6.8M
Q1 24
$-29.3M
$1.9M
Free Cash Flow
FHTX
FHTX
INTG
INTG
Q4 25
$-481.0K
Q3 25
$-1.3M
Q2 25
$-21.0M
$3.6M
Q1 25
$-24.0M
$-1.2M
Q4 24
$-25.0M
$-1.1M
Q3 24
$-21.3M
$3.1M
Q2 24
$-25.6M
$2.7M
Q1 24
$-29.4M
$1.1M
FCF Margin
FHTX
FHTX
INTG
INTG
Q4 25
-2.8%
Q3 25
-7.1%
Q2 25
-278.2%
22.5%
Q1 25
-403.2%
-6.8%
Q4 24
-875.3%
-7.8%
Q3 24
-273.0%
18.3%
Q2 24
-371.0%
20.4%
Q1 24
-583.1%
7.6%
Capex Intensity
FHTX
FHTX
INTG
INTG
Q4 25
0.0%
2.6%
Q3 25
0.0%
5.4%
Q2 25
0.3%
13.9%
Q1 25
0.5%
1.8%
Q4 24
16.8%
2.4%
Q3 24
4.0%
1.6%
Q2 24
0.2%
30.4%
Q1 24
2.0%
4.9%
Cash Conversion
FHTX
FHTX
INTG
INTG
Q4 25
-0.02×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FHTX
FHTX

Segment breakdown not available.

INTG
INTG

Hotel Operations$12.7M73%
Real Estate Operation$4.6M27%

Related Comparisons